Evidence map›Paper›PMID 39933762›Full record

ArticleSaudi medical journal2025

GLP-1RA and SGLT2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ASCVD) or at high risk of ASCVD in the Gulf Region: Results from the PACT-MEA studys.

Waleed A Al-Dahi, Saeed H Khalaf, Dalal A AlRomaihi, Naji M Alamuddin, Hessa M Al Kandari, Doaa K Abdalla, Hanan Y Alfadehla, Amin A Jayyousi, Mashhood A Siddique, Usama A AlAlami and 3 more

Abstract read
In one paragraph

Article in Saudi medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting-Expert Group Recommendations from Kuwait.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Review
  2. Use of Fixed Ratio Combinations to Improve Glycemic Control in Individuals with Type 2 Diabetes: Experts' Opinion from the Gulf Region.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Waleed A Al-DahiFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Saeed H KhalafFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Dalal A AlRomaihiFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Naji M AlamuddinFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Hessa M Al KandariFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Doaa K AbdallaFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Hanan Y AlfadehlaFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Amin A JayyousiFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Mashhood A SiddiqueFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Usama A AlAlamiFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Guruprasad C SubbaraoFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Shashikanth J ChettyFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.
Jehan A AbdullaFrom the Department of Internal Medicine (Al-Dahi), Mubarak Hospital, Al Jairiyah; from the Department of Pediatric Endocrinology (Al Kandari), Farwaniya Hospital; from the Department of Endocrinology (Al Kandari, Abdalla), Dasman Diabetes Institute, Dasma; from the Department of Primary Care (Abdalla, Alfadehla) Yarmouk Primary Health Care Centre, Al Yarmūk; from the Department of Medical Affairs (AlAlami, Subbarao, Chetty), Novo Nordisk Gulf Cluster, Salmiya, Kuwait; from the Department of Endocrinology (Khalaf), Salmaniya Medical Complex, Manama; from the Department of Endocrinology (AlRomaihi), Awali Hospital, Awali; Department of Internal Medicine (Alamuddin), King Hamad University Hospital, Adliya; from the Department of Endocrinology (Abdulla), Bahrain Defence Force Hospital, West Riffa, Bahrain; and from the Department of Endocrinology (Jayyousi, Siddique), Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0003-0393-9139

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo provide insights into the real-world usage of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) among individuals with type 2 diabetes (T2D) from Bahrain, Kuwait, and Qatar who either had established atherosclerotic cardiovascular disease (eASCVD) or were at high risk of developing ASCVD.

methodsThis study of 1062 adults diagnosed with T2D from Bahrain, Kuwait, and Qatar is a sub-analysis within the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients with Type 2 Diabetes across Countries in the Middle East and Africa (PACT-MEA) study, a noninterventional, cross-sectional study. Participants were recruited from 13 primary or secondary care facilities between March and August 2022. Medical records of participants were reviewed to extract relevant data, including demographic characteristics, eASCVD status, ASCVD risk and glucose-lowering treatment. Appropriate descriptive and inferential statistical tests were performed.

resultsAmong T2D participants with eASCVD, a significantly higher proportion (41.3%) received SGLT2i compared to GLP-1RA (10.5%,

conclusionDespite these cardioprotective agents being recommended by guidelines, the study findings suggest a suboptimal use of GLP-1RA and SGLT2i in a real-world setting.

Indexed as

AtherosclerosisDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsSodium-Glucose Transporter 2 InhibitorsAdultAgedBahrainCross-Sectional StudiesFemaleHumansKuwaitMaleMiddle AgedMiddle EastQatarGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsSodium-Glucose Transporter 2 Inhibitorsatherosclerosiscardiovascular diseasesDiabetes mellitushypoglycemic agentsMiddle Easttype 2

Identifiers

PMID39933762
PMCPMC11822930

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.